Shopping Cart 0
Cart Subtotal
AED 0

2020 GeneSystems Inc - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company. The company discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of lung cancer, personalized medicine, and biological detection. 20/20 Gene's blood test technology is used in the early detection of lung cancer and provides method for analysis of cell signaling in tissue and technologies to detect biological toxins. The company offers its products and services to drug companies, biodefense specialists and life scientists for protein analysis. 20/20 Gene is headquartered in Rockville, Maryland, the US.

2020 GeneSystems Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

20/20 GeneSystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

20/20 GeneSystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

20/20 GeneSystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

20/20 GeneSystems Inc, Medical Equipment, Deal Details 10

Venture Financing 10

20/20 GeneSystems Raises USD2 Million in Financing Round 10

20/20 GeneSystems Raises USD4.5 Million in Series A Financing 11

20/20 GeneSystems Raises USD2 Million in Financing 12

20/20 Gene Systems Raises USD1 Million in Financing Round 13

20/20 GeneSystems To Raise USD 5 Million In Venture Financing 14

20/20 GeneSystems Secures USD0.15 Million in Venture Funding from Maryland Venture Fund 15

Equity Offering 16

20/20 GeneSystems Raises Funds through Private Placement 16

Acquisition 17

BHC Center of Financial & Investment Acquires Stake in 20/20 GeneSystems 17

20/20 GeneSystems Inc-Key Competitors 18

20/20 GeneSystems Inc-Key Employees 19

20/20 GeneSystems Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Product News 21

Aug 21, 2017: 20/20's Lung Cancer Detection Technology Launches in China 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

20/20 GeneSystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

20/20 GeneSystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

20/20 GeneSystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

20/20 GeneSystems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

20/20 GeneSystems Inc, Medical Equipment, Key Facts 2

20/20 GeneSystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

20/20 GeneSystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

20/20 GeneSystems Inc, Deals By Market, 2012 to YTD 2018 8

20/20 GeneSystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

20/20 GeneSystems Raises USD2 Million in Financing Round 10

20/20 GeneSystems Raises USD4.5 Million in Series A Financing 11

20/20 GeneSystems Raises USD2 Million in Financing 12

20/20 Gene Systems Raises USD1 Million in Financing Round 13

20/20 GeneSystems To Raise USD 5 Million In Venture Financing 14

20/20 GeneSystems Secures USD0.15 Million in Venture Funding from Maryland Venture Fund 15

20/20 GeneSystems Raises Funds through Private Placement 16

BHC Center of Financial & Investment Acquires Stake in 20/20 GeneSystems 17

20/20 GeneSystems Inc, Key Competitors 18

20/20 GeneSystems Inc, Key Employees 19

20/20 GeneSystems Inc, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

2020 GeneSystems Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.